| Dr Howard J Quan, DDS | |
|
540 N Central Ave, Ste 204, Glendale, CA 91203-1916 | |
| (818) 241-5510 | |
| (818) 242-2650 |
| Full Name | Dr Howard J Quan |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 540 N Central Ave, Glendale, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275695785 | NPI | - | NPPES |
| B26113-01 | Other | CA | CA MEDICAL DENTAL PROGRAM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 26113 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Howard J Quan, DDS 540 N Central Ave, Ste 204, Glendale, CA 91203-1916 Ph: (818) 241-5510 | Dr Howard J Quan, DDS 540 N Central Ave, Ste 204, Glendale, CA 91203-1916 Ph: (818) 241-5510 |
News Archive
What is the fourth leading cause of death in the United States? Many would be surprised to learn that chronic obstructive pulmonary disease (COPD) is, and the number of people with COPD is increasing. According to the COPD Foundation, more than 12 million Americans are currently diagnosed with COPD and an additional 12 million may not realize their shortness of breath and coughing are in fact symptoms of this debilitating condition.
Two multi-gene tests designed to predict the risk of disease progression and response to chemotherapy in breast cancer produce broadly similar results for high- and low-risk patients, but do not always agree in their predictions for those at intermediate risk, a new analysis shows.
Mevion Medical Systems, the leader in compact proton therapy, is announcing that University Hospitals in Cleveland used the industry-leading MEVION S250 proton therapy system to treat its first patient, a 24-year-old woman with, rhabdomyosarcoma, a rare form of sarcoma. The proton therapy treatment made history by being the first in the state of Ohio.
Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACU-4429, an investigational oral treatment for dry age-related macular degeneration (dry AMD).
› Verified 8 days ago
Dr. Alenush D Bernardi, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1110 N Brand Blvd Ste 201, Glendale, CA 91202 Phone: 818-244-0215 | |
Dr. Lyla A. Gazarian-boustani, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 230 N Maryland Ave, Suite 206, Glendale, CA 91206 Phone: 818-547-2804 | |
Maricel Guarin Fortin, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1415 E Colorado St, Ste C, Glendale, CA 91205 Phone: 818-545-7270 | |
Dr. Lloyd Thomas Turner, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1111 N Brand Blvd, Suite B, Glendale, CA 91202 Phone: 818-246-5611 | |
Alexander Lalabekyan, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 457 W Colorado St, Suite#201, Glendale, CA 91204 Phone: 818-543-0707 Fax: 818-543-0700 | |
Andre Eliasian, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1249 W Glenoaks Blvd, Glendale, CA 91201 Phone: 818-649-1772 Fax: 818-649-1774 | |
Dr. Greg Tashdjian, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 316 E Broadway, Glendale, CA 91205 Phone: 818-548-7700 |